Pricing Log in Create free account

Cibus, Inc. (CBUS) vs Immunic, Inc. (IMUX)

Cibus, Inc. and Immunic, Inc. are both Biotechnology companies. Cibus, Inc. and Immunic, Inc. are of similar size ($98.6M and $96.9M). Immunic, Inc. has the higher net margin (0.00% vs −2,258.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Immunic, Inc. leads on 9 and Cibus, Inc. on 4.

Valuation

Metric CBUS IMUX Biotechnology median
P/E n/m n/m 8.50
P/S 23.31 n/m 9.71
P/B 6.84 2.32 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 18.85 n/m 9.21
Earnings yield (125.00%) (62.84%) (33.15%)
Free cash flow yield (45.68%) (29.71%) (25.50%)

Profitability

Metric CBUS IMUX Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,450.59%) 0.00% 0.00%
Net margin (2,258.89%) 0.00% 0.00%
Free cash flow margin (1,064.60%) 0.00% 0.00%
Return on equity (219.97%) (138.17%) (56.36%)
Return on assets (29.77%) (101.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CBUS IMUX Biotechnology median
Revenue growth (TTM) (10.30%) — 6.02%
EPS growth (last fiscal year) 74.33% 38.00% 30.26%
Revenue growth, 5-year CAGR (31.34%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CBUS IMUX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.62 5.05 4.72
Net debt to EBITDA (0.28) 0.15 0.96

Dividend

Metric CBUS IMUX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CBUS IMUX Biotechnology median
Market cap 98.59m 96.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack